STOCK TITAN
  1. Home
  2. Financials
  3. BTAI
  4. Revenue

BioXcel Therapeutics, Inc. (BTAI) Revenue by Year

BTAI

BioXcel Therapeutics, Inc. generated $642K in revenue in fiscal year 2025. This represents a decrease of 71.7% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $742K in revenue. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters BioXcel Therapeutics, Inc. has filed alongside them.

FY2025 annual
Revenue $642K
YoY -71.7%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

BTAI Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-K
Revenue$742K$642K-71.7%$2.3M+64.2%$1.4M+268.0%$375KN/AN/AN/AN/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

BTAI Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$182K+51.7%$206K+22.6%$256K-30.1%$98K-54.2%$120K-89.1%$168K-71.1%$366K-2.7%$214K-37.2%$1.1M+141.6%$582K+182.5%$376K$341K+148.9%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More BioXcel Therapeutics, Inc. financials

Frequently Asked Questions

What was BioXcel Therapeutics, Inc.'s revenue in fiscal year 2025?

BioXcel Therapeutics, Inc. generated $642K in revenue in fiscal year 2025.

How fast is BioXcel Therapeutics, Inc.'s revenue growing?

BioXcel Therapeutics, Inc. (BTAI) revenue fell by 71.7% year over year, from $2.3M to $642K in fiscal year 2025.

What is BioXcel Therapeutics, Inc.'s revenue over the last twelve months?

BioXcel Therapeutics, Inc. (BTAI) reported $742K in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

BioXcel Therapeutics, Inc. (BTAI) reported $182K in revenue in Q2 2026. This represents an increase of 51.7% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what BioXcel Therapeutics, Inc. (BTAI) reported on that line in every period on record.